1-4 of 4
Ellen Cusano
Close
Sort by
Journal Articles

Prevalence and Risk Factors of Diagnostic Delays in Acquired Hemophilia A

Bradley Rutherford, Ellen Cusano, M. Dawn Goodyear, Haowei (Linda) Sun
Journal: Blood
Blood (2023) 142 (Supplement 1): 2627.
https://doi.org/10.1182/blood-2023-185210
Published: 2023
Journal Articles

Appropriateness of Immunosuppression and Blood Product Utilization in Acquired Hemophilia A: A Multicentre Provincial Practice Audit

Bradley Rutherford, Ellen Cusano, M. Dawn Goodyear, Haowei (Linda) Sun
Journal: Blood
Blood (2023) 142 (Supplement 1): 2313.
https://doi.org/10.1182/blood-2023-187702
Published: 2023
Journal Articles

Comparison of Activated Clotting Time to Hepcon Protamine Titration for Anticoagulation Management during Cardiopulmonary Bypass Surgery in a Patient with Severe Hemophilia a on Emicizumab Prophylaxis

Ellen Cusano, Haowei Linda Sun, M Dawn Goodyear, Man-Chiu Poon, Douglas Seal, R Scott McClure, Natalia Rydz
Journal: Blood
Blood (2022) 140 (Supplement 1): 2759–2761.
https://doi.org/10.1182/blood-2022-168133
Published: 2022
Journal Articles

Case Series: Outcome and Cost Analysis of Rituximab Versus Non-Targeted Immunosuppression As First Line Inhibitor Eradication in Acquired Hemophilia a

Ellen Cusano, Adrienne Lee, MD, Julia Hews-Girard, RN BScN MN
Journal: Blood
Blood (2019) 134 (Supplement_1): 2399.
https://doi.org/10.1182/blood-2019-129665
Published: 2019